ALS Invest 1 B.V.

Insider Reports History

Location
Amsterdam, Netherlands
Signature
/s/ Felix-Andre von Coerper
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by ALS Invest 1 B.V.:

Company Role Class Num Shares Value Price $ Report Date Ownership
Amylyx Pharmaceuticals, Inc. 10%+ Owner Common Stock 5,895,280 $96,258,721 $16.33 06 Jul 2022 Direct

Insider Reports Filed by ALS Invest 1 B.V.

Symbol Company Period Transactions Value $ Form Type Role Filing Time
AMLX Amylyx Pharmaceuticals, Inc. 06 Jul 2022 4 -$1,254,642 4 10%+ Owner 08 Jul 2022, 18:44
AMLX Amylyx Pharmaceuticals, Inc. 06 Jan 2022 4 $0 4 10%+ Owner 05 May 2022, 16:46
AMLX Amylyx Pharmaceuticals, Inc. 06 Jan 2022 0 $0 3 10%+ Owner 05 May 2022, 16:42